Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
64.89
USD
+0.23 (+0.36%)
Official Closing Price
Updated: 6:27 PM EDT, Apr 13, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Gilead Sciences
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
A Short Delay Is Still Bad News for AbbVie
Today 8:02 EDT
Rinvoq's FDA approval decision could be a sign the drug class is under investigation.
Tags
PFE
INCY
LLY
From
Motley Fool
How To Play Lagging Healthcare Stocks
Today 6:50 EDT
The Healthcare Select SPDR Fund (XLV) gives you the most diversified play in healthcare returning 11.4% in ’20 and 4% YTD.
Tags
ETFs
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Notable Monday Option Activity: FAST, GILD, WMT
April 12, 2021
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Fastenal Co. (FAST), where a total of 20,167 contracts have traded so far, representing...
Tags
Stocks
From
Market News Video
Biotech Stocks Could Use A Win — Will The First Quarter Offer That?
April 08, 2021
Gilead Sciences, Biogen and Vertex Pharmaceuticals could top expectations in an otherwise soft quarter for biotech stocks, an analyst said Thursday. He sees key products beating forecasts.
From
Investor's Business Daily
A Look Into Gilead Sciences Price Over Earnings
April 08, 2021
Looking into the current session, Gilead Sciences Inc. (NASDAQ:GILD) shares are trading at $65.61, after a 0.1% ...
Tags
News
GILD
Markets
From
Benzinga
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
April 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SGTX
FDA
LLY
From
Benzinga
Is Gilead Sciences Stock a Buy?
April 08, 2021
This is one contrarian investment you don't want to miss out on.
Tags
IBB
Market News
GILD
From
Motley Fool
Gilead's Trodelvy Wins FDA Regular Approval For Triple-Negative Breast Cancer
April 08, 2021
TheFDA has granted regular approvaltoGilead Sciences Inc's(NASDAQ:GILD) Trodelvy (sacituzumab ...
Tags
Market News
breast cancer
Benzinga
From
Benzinga
Exclusive: Precigen's CEO Breaks Down Biotech's Oncology Platforms, Technology, Differentiators
April 06, 2021
Cancer treatment has evolved from the use of chemotherapeutic anti-tumor drugs to targeted therapies to monoclonal antibodies to ...
Tags
General
PGEN
oncology
From
Benzinga
Why Phase 2 Trials Are Important To Investors (And Why I’m Enrolled In One)
April 06, 2021
The biotech sector tends to attract investors who are interested in exciting new medical advances and are drawn to big profits. There are lots of ways to invest in the sector.
Tags
Healthcare
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Novel Cancer Therapy Phase 3 Trial Expects To Be Completed Shortly
April 06, 2021
The following article is sponsored by Actinium Pharmaceuticals, Inc. The information contained in this article in no way represents ...
Tags
General
VKTX
News
From
Benzinga
Easter Monday
April 05, 2021
With so many foreign markets closed, the boom was biggest for USA large caps. But there was enough fringe movement elsewhere as well.
Tags
Stocks / Equities
Market News
From
Blogs - TalkMarkets
4 Biotech Stocks To Buy For The Q2 2021
April 05, 2021
The global biotechnology market is expected to expand at a CAGR of 15.8% between 2021 – 2028.
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Better Buy for 2021: Pfizer or Gilead?
April 05, 2021
In a post-pandemic world, one company has the lower valuation and higher dividend yield to be a success.
Tags
IHE
BNTX
Market News
From
Motley Fool
Week In Review: Three China In-Licensing Deals Add Up To $662 Million
April 03, 2021
Simcere Pharma of Nanjing announced a $292 million agreement to develop a proposed Kazia Therapeutics treatment for glioma in Greater China. Qihan Biotechnology raised $67 million in a Series A++ round...
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
3 Dependable Dividend Stocks to Buy in April
April 03, 2021
Looking for a steady stream of income? These are companies you can count on.
Tags
ADP
MRK
GILD
From
Motley Fool
Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake
April 02, 2021
It's never a bad time to search for beaten-down stocks that are profitable on paper.
Tags
GILD
DKNG
TUP
From
Motley Fool
7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic
April 01, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Covid-19 has put healthcare stocks in the limelight. These seven...
Tags
TMO
ABT
Market News
From
InvestorPlace
Top Stocks To Buy Now? 4 Health Care Stocks To Watch
April 01, 2021
Tags
Market News
From
StockMarket.com
AbCellera, Gilead Ink New Multi-Target Antibody Discovery Collaboration
April 01, 2021
AbCellera Biologics Inc(NASDAQ:ABCL) hasannounced agreements to expand its collaborationwithGilead ...
Tags
News
Biotech
GILD
From
Benzinga
This Big Leap in Cancer Treatment Could Change the Landscape
April 01, 2021
TIL therapy looks able to win a large addressable market, and Iovance is the leader of the pack.
Tags
Market News
IOVA
GILD
From
Motley Fool
Gilead Sciences Bull Flag Breakout Nearing
March 31, 2021
Shares of Gilead Sciences have been chopping sideways over the last three months. This has formed a beautiful Gilead Sciences bull flag and sets up for a big breakout.
Tags
Stocks / Equities
Healthcare
Market News
From
Blogs - TalkMarkets
Pharma and Biotech Stocks On Sale
March 31, 2021
Healthcare represents a fertile field for value-oriented investors seeking good investments that simultaneously provide a margin of safety.
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
Could Regeneron's Antibody Therapy Be as Important as Vaccines in Fighting COVID?
March 31, 2021
There are a couple of obstacles that could get in the way.
Tags
Market News
REGN
GILD
From
Motley Fool
Everest Approved for China Phase II trial of Trodelvy® in TROP-2 Cancers
March 31, 2021
Shanghai 's Everest Medicines said it is approved to conduct a China Phase II trial of Trodelvy® in patients with cancers that have high TROP-2 expression. Everest plans to enroll 180 patients with...
From
ChinaBio® Today
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2021
March 30, 2021
Upgrades According to Seaport Global, the prior rating for Clearway Energy Inc (NYSE:CWEN) was changed from Neutral to ...
Tags
TXN
RNSHF
FCEL
From
Benzinga
Why Humanigen Stock Is Skyrocketing Today
March 29, 2021
The company's investigational coronavirus treatment could hit the market soon.
Tags
Market News
HGEN
LLY
From
Motley Fool
Why Humanigen, uniQure, bluebird bio, Amphastar Are Rallying Monday
March 29, 2021
Humanigen, Inc. (NASDAQ: HGEN), uniQure N.V. (NASDAQ: QURE), bluebird bio, Inc. (NASDAQ: BLUE) and Amphastar Pharmaceuticals, Inc. ...
Tags
Market News
BLUE
Small Cap
From
Benzinga
Best Stocks To Buy In April 2021? 4 Biotech Stocks To Watch This Week
March 28, 2021
Tags
Market News
From
StockMarket.com
Noteworthy ETF Outflows: IXJ, JNJ, ABT, GILD
March 26, 2021
Symbols mentioned in this story: IXJ, JNJ, ABT, GILD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.